症状性颅内动脉粥样硬化性狭窄的球囊扩张与支架置入:NeuroSpeed球囊导管与CREDO heal支架的双中心经验
这项回顾性双中心研究纳入42例症状性颅内动脉粥样硬化性狭窄患者,使用NeuroSpeed球囊导管和CREDO heal支架行颅内支架置入,分为ICAS组(n=23)和补救支架组(n=19)。技术成功率为83%,改良Rankin量表中位数从基线2降至随访0(p=0.005),短期临床结局良好,并发症发生率可接受。
要点
- NeuroSpeed球囊导管联合CREDO heal支架治疗症状性ICAS技术成功率为83%。
- 随访mRS中位数从2降至0,提示短期临床改善显著。
- 补救支架组急性支架闭塞发生率10.5%,ICAS组迟发性无症状支架闭塞8.7%。
英文原文(摘要)· 点击展开
BACKGROUND: Intracranial atherosclerotic stenosis (ICAS) remains a significant cause of recurrent ischemic strokes. While aggressive medical management is the mainstay of treatment, percutaneous transluminal angioplasty (PTA) and intracranial stenting (ICS) are increasingly used, especially in cases refractory to medical therapy or as a bailout during frustrating thrombectomy.
OBJECTIVE: To evaluate the safety, technical feasibility, and short-term outcomes of NeuroSpeed balloon-catheter angioplasty and CREDO heal stent implantation in patients with symptomatic ICAS with and without large or medium vessel occlusion (LVO/MeVO).
METHODS: This retrospective, dual-center study included 42 patients who underwent ICS using the NeuroSpeed balloon-catheter and fibrin-heparin coated CREDO heal stent. Patients were divided into two subgroups: ICAS (n = 23) and Bailout stenting (n = 19). Procedural success with a stenosis grade reduction to ≤ 50%, complication rates, and clinical outcomes were analyzed.
RESULTS: Technical success was achieved in 83% of cases. Clinical improvement was significant between baseline and follow-up, with a reduction in the median modified Rankin Scale score from 2 to 0 (p = 0.005). Acute stent occlusion occurred in 2 of 19 patients (10.5%) in the bailout group. Late vascular follow-up imaging was available in 30 patients; two asymptomatic delayed stent occlusions occurred in the ICAS group (2/23, 8.7%) and two cases of in-stent restenosis in the bailout group (2/19, 10.5%). Procedure-related intracranial hemorrhage occurred in one patient in the ICAS group (1/23, 4.3%) and one patient in the bailout group (1/19, 5.3%). One access-site pseudoaneurysm (1/42, 2.4%) was observed.
CONCLUSION: NeuroSpeed/CREDO-based intracranial stenting appears to be a technically feasible treatment for high-grade ICAS and as a bailout during thrombectomy, with favorable short-term clinical outcomes and acceptable complication rates. Further prospective studies are warranted to assess long-term safety, efficacy, and durability.
引用
- Alsady TM, Aburub A, Dob O, et al. Angioplasty and stenting of symptomatic intracranial atherosclerotic stenosis: a dual-center experience using NeuroSpeed balloon-catheter and CREDO heal stent. Neuroradiology. 2026. PMID: 42742684. doi:10.1007/s00234-026-04181-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。